Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MigraSoothe is a specialized consumer healthcare company focused on providing evidence-based nutritional interventions for migraine management. The company's product portfolio centers on high-dose riboflavin (Vitamin B2), magnesium, and Coenzyme Q10 formulations, which are designed to support mitochondrial energy metabolism and reduce the frequency and intensity of migraine attacks. MigraSoothe positions itself as a natural alternative or adjunct to traditional pharmaceutical migraine preventatives, adhering to guidelines suggested by neurological associations. Their products are primarily distributed through direct-to-consumer e-commerce channels and specialized health retailers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MigraSoothe.